These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33791990)

  • 41. Recent advances in the metabolomic study of bladder cancer.
    Amara CS; Vantaku V; Lotan Y; Putluri N
    Expert Rev Proteomics; 2019 Apr; 16(4):315-324. PubMed ID: 30773067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Applications of metabolomics to study cancer metabolism.
    Kaushik AK; DeBerardinis RJ
    Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):2-14. PubMed ID: 29702206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolomics studies in gastrointestinal cancer: a systematic review.
    Yu J; Zhao J; Zhang M; Guo J; Liu X; Liu L
    Expert Rev Gastroenterol Hepatol; 2020 Jan; 14(1):9-25. PubMed ID: 31786962
    [No Abstract]   [Full Text] [Related]  

  • 44. Metabolomics Analyses of Cancer Cells in Controlled Microenvironments.
    Gravel SP; Avizonis D; St-Pierre J
    Methods Mol Biol; 2016; 1458():273-90. PubMed ID: 27581029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer Metabolomics and the Human Metabolome Database.
    Wishart DS; Mandal R; Stanislaus A; Ramirez-Gaona M
    Metabolites; 2016 Mar; 6(1):. PubMed ID: 26950159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A serum metabolomics study of gastric cancer based on pseudotargeted liquid chromatography-mass spectrometry approach].
    Yang T; Luo P; Li Y; Hua R; Yin P; Xu G
    Se Pu; 2014 Feb; 32(2):126-32. PubMed ID: 24822445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies.
    Lima AR; Bastos Mde L; Carvalho M; Guedes de Pinho P
    Transl Oncol; 2016 Aug; 9(4):357-70. PubMed ID: 27567960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive Multi-Omics Analysis Reveals Aberrant Metabolism of Epstein-Barr-Virus-Associated Gastric Carcinoma.
    Yoon SJ; Kim JY; Long NP; Min JE; Kim HM; Yoon JH; Anh NH; Park MC; Kwon SW; Lee SK
    Cells; 2019 Oct; 8(10):. PubMed ID: 31597357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolomics facilitates the discovery of metabolic biomarkers and pathways for ischemic stroke: a systematic review.
    Ke C; Pan CW; Zhang Y; Zhu X; Zhang Y
    Metabolomics; 2019 Nov; 15(12):152. PubMed ID: 31754808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progress in research on the role of amino acid metabolic reprogramming in tumour therapy: A review.
    Wang D; Wan X
    Biomed Pharmacother; 2022 Dec; 156():113923. PubMed ID: 36411616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolomics assisted metabolic network modeling and network wide analysis of metabolites in microbiology.
    Wang J; Wang C; Liu H; Qi H; Chen H; Wen J
    Crit Rev Biotechnol; 2018 Nov; 38(7):1106-1120. PubMed ID: 29683004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional metabolomics: from biomarker discovery to metabolome reprogramming.
    Peng B; Li H; Peng XX
    Protein Cell; 2015 Sep; 6(9):628-37. PubMed ID: 26135925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment.
    Al-Ansari MM; AlMalki RH; Dahabiyeh LA; Abdel Rahman AM
    Metabolites; 2021 Nov; 11(11):. PubMed ID: 34822416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma.
    Lucarelli G; Loizzo D; Franzin R; Battaglia S; Ferro M; Cantiello F; Castellano G; Bettocchi C; Ditonno P; Battaglia M
    Expert Rev Mol Diagn; 2019 May; 19(5):397-407. PubMed ID: 30983433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.
    Wang Y; Wang CH; Zhang YF; Zhu L; Lei HM; Tang YB
    Metabolomics; 2019 Mar; 15(4):52. PubMed ID: 30911937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolomics approach based on utra-performance liquid chromatography coupled to mass spectrometry with chemometrics methods for high-throughput analysis of metabolite biomarkers to explore the abnormal metabolic pathways associated with myocardial dysfunction.
    Zhao LK; Zhao YB; Yu PC; Zhang PX
    Biomed Chromatogr; 2020 Aug; 34(8):e4847. PubMed ID: 32285481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultraperformance liquid chromatography-mass spectrometry based comprehensive metabolomics combined with pattern recognition and network analysis methods for characterization of metabolites and metabolic pathways from biological data sets.
    Zhang AH; Sun H; Han Y; Yan GL; Yuan Y; Song GC; Yuan XX; Xie N; Wang XJ
    Anal Chem; 2013 Aug; 85(15):7606-12. PubMed ID: 23845028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer metabolomics in basic science perspective.
    Kwon H; Oh S; Jin X; An YJ; Park S
    Arch Pharm Res; 2015 Mar; 38(3):372-80. PubMed ID: 25630795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites.
    Yue X; He J; Zhang R; Xu J; Zhou Z; Zhang R; Bi N; Wang Z; Sun C; Wang L; Chen Y; Abliz Z
    J Chromatogr A; 2018 Dec; 1580():80-89. PubMed ID: 30473010
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrated gene-metabolite association network analysis reveals key metabolic pathways in gastric adenocarcinoma.
    Xu B; Shi Y; Yuan C; Wang Z; Chen Q; Wang C; Chai J
    Heliyon; 2024 Sep; 10(17):e37156. PubMed ID: 39319160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.